The new agent upgrades the Databricks Assistant, enabling it to help data practitioners complete repetitive tasks and ...

Overview: Discover the real people behind statistics that power our world.Understand how their innovations shaped science, ...

Perioperative nivolumab in eligible patients with resectable non-small cell lung cancer offers improved survival outcomes and ...

Late-breaking data from exploratory analyses at WCLC show Libtayo plus chemotherapy demonstrates a more than double five-year overall survival rate of 19.4%, compared to 8.8% with chemotherapy alone ...

Explore the importance of robust statistics like median and MAD in data analysis, ensuring accurate insights despite outliers ...

Industry watchers who cheered on Summit Therapeutics’ claim that the first global phase 3 trial of its Akeso-partnered ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on Tuesday announced five-year follow-up results on overall survival (OS) from ...

Sphinx, the company building AI for data, launched today with a $9.5 million Seed round and an AI copilot for data professionals to transform raw information into actionable insights. The round was ...

The ORR is down slightly from the rate seen in an earlier stage of the trial, in which the B7-H3-directed ADC was tied to a ...

When people think of nature sounds, they likely imagine birds singing at dawn or frogs calling after rain. But beneath the ...

Regeneron's Phase 3 trials for cat and birch allergies show significant symptom relief and strong safety results, paving the ...